Vision

Leading automation and intelligence technologies enable breakthrough innovations and productivity revolution, engineering a more efficient, vivid and beautiful world.

ABOUT MEGAROBO

Since the establishment in 2016, MEGAROBO has been devoting in becoming an intelligent automation expert in life sciences, clinical diagnostics, applied chemistry, advanced manufacturing and more fields, enabling breakthrough innovation of industry and productivity to create a more efficient, healthier and better world.

MEGAROBO is focusing on robotics and AI technology R&D applied in industrial scenarios, where we provide intelligent automation products and total solutions to our partners. With MEGALAB, an automated intelligent life sciences lab developed by MEGAROBO, we enable automation transformation in drug discovery and development, cell and gene therapy, organoid development, and synthetic biology.

Additionally, MEGAROBO is a leading innovator in the semiconductor manufacturing and testing equipment industry, providing numerous mature products and solutions to top industry players.

MEGAROBO has assembled a talent and interdisciplinary team including close to 100 scientists with PhD degrees and 500 experienced engineers and has filed over 350 patents. MEGAROBO is headquartered in Suzhou, China, with local branches in Beijing, Shanghai, and Shenzhen. And overseas headquarters is located in Singapore, with R&D centers in the United States, the United Kingdom and Japan.

MEGAROBO has closed the Series C financing. We have been favoured and recognized by many top strategic and institutional investors, such as WuXi AppTec, Bosch, Goldman Sachs Asset Management, Asia Investment Capital, GGV Capital, Sinovation Ventures, Joy Capital, and Matrix Partners China, Pavilion Capital.

Our Team

  • 1000+

    Employees

  • 60%

    R&D personnel

  • 60%

    Master degree or above

  • 40%

    Interdisciplinary talents

  • 300+

    Patent applications

Milestone

2016

June
Founded in Beijing
Pioneer in life sciences automation solutions market

2017

June
Angel round

2018

November
Suzhou delivery center started operation
Entered into advanced/smart manufacturing solutions market

2019

April
Series A/A+ rounds led by BOSCH
December
MagaRobo’s life sciences lab in operation
Entered into life sciences research services market

2020

August
Developed world’s first high-throughput sample processing and RNA extraction instruments for Covid PCR test
November
Shenzhen delivery center started operation
Entered into semiconductor testing equipment solutions market

2021

May
Series B1/B2/B3 rounds led by Sinovation Ventures/Matrix Partners /WuXi AppTec
August
MegaLab phase I by MEGAROBO established in Beijing
September
Intelligent genetic engineering lab established in Shanghai
Entered into cell and gene therapy solution services market
December
MEGAROBO's annual output value exceeds 400 million yuan

2022

April
Series C round led by Goldman Sachs, Asia Investment Capital, GGV
June
Head offices in Singapore, US and Japan established
Global expansion initiated

GLOBAL FOOTPRINT


Qualification and honor


ISO 9001

ISO 13485

EU DOC Certification

UDEM Certification

Beijing Technologically Advanced ‘Little Giant’ Enterprises

MIT Technology Review - 50 Smartest Companies in China 2021

Deloitte China Rising Star 2020

DNA Paris Design Awards 2022

Spark Design Awards 2021

IDA Design Awards 2021

Contemporary Good Design Award 2021
0.085731s